Skip to main content
. 2019 Jul 5;9:9731. doi: 10.1038/s41598-019-46282-w

Table 2.

Significant gene set enrichment (category “biological process”, Fisher’s exact test: < 0.01) based on differentially regulated genes by MiuA compared to jasplakinolide.

GO, ID Term Annotated Significant Expected Fisher
GO:0071456 cellular response to hypoxia 146 7 1,09 0,00011
GO:0030509 BMP signaling pathway 90 7 0,67 0,00015
GO:0030900 forebrain development 213 8 1,6 0,00018
GO:0045446 endothelial cell differentiation 74 5 0,55 0,00022
GO:0007568 aging 194 7 1,45 0,0006
GO:0043280 positive regulation of cysteine-type endopeptidase activity involved in apoptotic process 92 5 0,69 0,00061
GO:0045666 positive regulation of neuron differentiation 202 7 1,51 0,00077
GO:0043410 positive regulation of MAPK cascade 272 8 2,04 0,00094
GO:0006935 chemotaxis 295 8 2,21 0,00158
GO:0032496 response to lipopolysaccharide 177 6 1,33 0,00207
GO:0002064 epithelial cell development 124 5 0,93 0,00233
GO:0001558 regulation of cell growth 260 7 1,95 0,00325
GO:0071902 positive regulation of protein serine/threonine kinase activity 198 6 1,48 0,00361
GO:0051051 negative regulation of transport 265 7 1,99 0,00361
GO:0072593 reactive oxygen species metabolic process 149 7 1,12 0,00471
GO:0051216 cartilage development 110 6 0,82 0,00545
GO:0043405 regulation of MAP kinase activity 218 6 1,63 0,00576
GO:0071560 cellular response to transforming growth factor beta stimulus 155 5 1,16 0,00604
GO:0006979 response to oxidative stress 300 7 2,25 0,00706
GO:0051155 positive regulation of striated muscle cell differentiation 31 5 0,23 0,00727

The GOs marked in bold are unique for the comparison MiuA vs. jasplakinolide and do not show up in MiuA or jasplakinolide vs. control.